120 related articles for article (PubMed ID: 6153126)
1. Measurements of prolactin and androgens in patients with prostatic diseases.
Saroff J; Kirdani RY; Chu TM; Wajsman Z; Murphy GP
Oncology; 1980; 37(1):46-52. PubMed ID: 6153126
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
Cochran RC; Ewing LL; Niswender GD
Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
[TBL] [Abstract][Full Text] [Related]
3. Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate.
Drafta D; Proca E; Zamfir V; Schindler AE; Neacşu E; Stroe E
J Steroid Biochem; 1982 Dec; 17(6):689-93. PubMed ID: 6184548
[TBL] [Abstract][Full Text] [Related]
4. Serum hormone levels among patients with prostatic carcinoma or benign prostatic hyperplasia and clinic controls.
Hulka BS; Hammond JE; DiFerdinando G; Mickey DD; Fried FA; Checkoway H; Stumpf WE; Beckman WC; Clark TD
Prostate; 1987; 11(2):171-82. PubMed ID: 2444956
[TBL] [Abstract][Full Text] [Related]
5. Interaction of prolactin and testosterone in the human prostate.
Farnsworth WE; Slaunwhite WR; Sharma M; Oseko F; Brown JR; Gonder MJ; Cartagena R
Urol Res; 1981; 9(2):79-88. PubMed ID: 6165128
[TBL] [Abstract][Full Text] [Related]
6. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer.
Rannikko S; Adlercreutz H
Prostate; 1983; 4(3):223-9. PubMed ID: 6189106
[TBL] [Abstract][Full Text] [Related]
7. Sex hormone binding globulin binding capacity, testosterone, 5alpha-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment.
Bartsch W; Horst HJ; Becker H; Nehse G
Acta Endocrinol (Copenh); 1977 Jul; 85(3):650-64. PubMed ID: 325982
[TBL] [Abstract][Full Text] [Related]
8. Responses of serum levels of testicular steroid hormones to hCG stimulation in patients with prostatic cancer and benign prostatic hypertrophy.
Isurugi K; Kanazawa M; Yanaihara T; Kambegawa A
Prostate Suppl; 1981; 1():19-26. PubMed ID: 6176980
[TBL] [Abstract][Full Text] [Related]
9. Androgens in patients with benign prostatic hyperplasia before and after prostatectomy.
Vermeulen A; De Sy W
J Clin Endocrinol Metab; 1976 Dec; 43(6):1250-4. PubMed ID: 63468
[TBL] [Abstract][Full Text] [Related]
10. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.
Habib FK; Lee IR; Stitch SR; Smith PH
J Endocrinol; 1976 Oct; 71(1):99-107. PubMed ID: 62008
[TBL] [Abstract][Full Text] [Related]
11. Hormone blood levels in patients with prostatic carcinoma and their relation to the type of carcinoma growth differentiation.
Bartsch W; Steins P; Becker H
Eur Urol; 1977; 3(1):47-52. PubMed ID: 837954
[TBL] [Abstract][Full Text] [Related]
12. The effects of endocrine therapy on plasma steroids in prostatic carcinoma patients.
Drafta D; Proca E; Schindler AE; Neacşu E; Zamfir V; Neagoe M; Teodosiu D
Endocrinologie; 1984; 22(3):191-7. PubMed ID: 6494786
[TBL] [Abstract][Full Text] [Related]
13. Serum steroids in normal males and patients with prostatic diseases.
Hammond GL; Kontturi M; Vihko P; Vihko R
Clin Endocrinol (Oxf); 1978 Aug; 9(2):113-21. PubMed ID: 81115
[TBL] [Abstract][Full Text] [Related]
14. Effects of tamoxifen on the levels of luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL), 17 beta-oestradiol (E2), total and free testosterone (T) and total and free dihydrotestosterone (DHT) in blood of patients with benign prostatic hyperplasia.
Stahl F; Schnorr D; Rohde W; Poppe I; Geier T; Dörner G
Exp Clin Endocrinol; 1983 Jul; 82(1):21-8. PubMed ID: 6193975
[TBL] [Abstract][Full Text] [Related]
15. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
Lloyd JW; Thomas JA; Mawhinney MG
Invest Urol; 1975 Nov; 13(3):220-22. PubMed ID: 53217
[TBL] [Abstract][Full Text] [Related]
16. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
[TBL] [Abstract][Full Text] [Related]
17. Serum dihydrotestosterone in patients with benign prostatic hypertrophy.
Ghanadian R; Lewis JG; Chisholm GD; O'Donoghue EP
Br J Urol; 1977 Nov; 49(6):541-4. PubMed ID: 73397
[TBL] [Abstract][Full Text] [Related]
18. Serum of patients with prostatic cancer or benign prostatic hypertrophy contains nonpolar testosterone.
Addo SB; Holland JF; Kirschenbaum A; Mandeli J; Hollander VP
Steroids; 1990 Nov; 55(11):491-4. PubMed ID: 1706116
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment hormone levels in prostatic cancer.
Haapiainen R; Rannikko S; Alfthan O; Adlercreutz H
Scand J Urol Nephrol Suppl; 1988; 110():137-43. PubMed ID: 3187401
[TBL] [Abstract][Full Text] [Related]
20. The effect of ergobromocriptine on serum testosterone and prolactin levels in patients with carcinoma of the prostate.
Taşar C; Akdaş A; Kirkali Z
Int Urol Nephrol; 1986; 18(1):71-4. PubMed ID: 2424860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
